Haynes BF - Search Results

1

Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.

Verkoczy L, Kelsoe G, Moody MA, Haynes BF. Verkoczy L, et al. Among authors: haynes bf. Curr Opin Immunol. 2011 Jun;23(3):383-90. doi: 10.1016/j.coi.2011.04.003. Epub 2011 Apr 27. Curr Opin Immunol. 2011. PMID: 21524897 Free PMC article. Review.

2

Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.

Hart MK, Palker TJ, Matthews TJ, Langlois AJ, Lerche NW, Martin ME, Scearce RM, McDanal C, Bolognesi DP, Haynes BF. Hart MK, et al. Among authors: haynes bf. J Immunol. 1990 Oct 15;145(8):2677-85. J Immunol. 1990. PMID: 1698859

3

Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.

Liao HX, Levesque MC, Patton K, Bergamo B, Jones D, Moody MA, Telen MJ, Haynes BF. Liao HX, et al. Among authors: haynes bf. J Immunol. 1993 Dec 1;151(11):6490-9. J Immunol. 1993. PMID: 7504022

4

NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus.

de Lorimier R, Moody MA, Haynes BF, Spicer LD. de Lorimier R, et al. Among authors: haynes bf. Biochemistry. 1994 Mar 1;33(8):2055-62. doi: 10.1021/bi00174a011. Biochemistry. 1994. PMID: 7509632

5

HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen.

Haynes BF, Moody MA, Heinley CS, Korber B, Millard WA, Scearce RM. Haynes BF, et al. AIDS Res Hum Retroviruses. 1995 Feb;11(2):211-21. doi: 10.1089/aid.1995.11.211. AIDS Res Hum Retroviruses. 1995. PMID: 7742036

6

Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.

Haynes BF, Yasutomi Y, Torres JV, Gardner MB, Langlios AJ, Bolognesi DP, Matthews TJ, Scearce RM, Jones DM, Moody MA, et al. Haynes BF, et al. Trans Assoc Am Physicians. 1993;106:33-41. Trans Assoc Am Physicians. 1993. PMID: 8036743 No abstract available.

7

Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.

Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C, et al. Haynes BF, et al. J Immunol. 1993 Aug 1;151(3):1646-53. J Immunol. 1993. PMID: 8335949

8

Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.

Vu HM, de Lorimier R, Moody MA, Haynes BF, Spicer LD. Vu HM, et al. Among authors: haynes bf. Biochemistry. 1996 Apr 23;35(16):5158-65. doi: 10.1021/bi952665x. Biochemistry. 1996. PMID: 8611499

9

HIV vaccines: where we are and where we are going.

Haynes BF. Haynes BF. Lancet. 1996 Oct 5;348(9032):933-7. doi: 10.1016/S0140-6736(96)09339-7. Lancet. 1996. PMID: 8843815 Review.

10

Update on the issues of HIV vaccine development.

Haynes BF, Putman SB, Weinberg JB. Haynes BF, et al. Ann Med. 1996 Feb;28(1):39-41. doi: 10.3109/07853899608999072. Ann Med. 1996. PMID: 8932504 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

783 results

Search Page

Filters